Simon Li - SciClone Pharmaceuticals Independent Director

Director

Mr. Simon Li is an Independent Director of SciClone Pharmaceuticals, Inc., since January 2013. Most recently, Mr. Li has served as a Director since January 2013. He is currently the Chairman and Chief Executive Officer of JW Medical System Ltd., an affiliated company of Biosensors International Ltd. From 2006 to 2012, Mr. Li served in various positions at Medtronic, a global medical technology company, including as the Global Officer and Member of the Executive Committee of Medtronic and President, Greater China and Chairman of the Board, MedtronicWeigao JV. Prior to Medtronic, from 1999 to 2005, Mr. Li served in various positions at Johnson Johnson Medical, China including International Vice President, North AsiaNew Business Development, Asia PacificStrategic Medical Affairs, Asia Pacific. Earlier in his career with JJ, he held the positions of International Vice President, North Asia, Managing Director, China and Hong Kong, and Managing Director, China. Prior to JJ, Mr. Li was President and Chief Operating Officer of the ConvaTec business with BristolMyers Squibb in Hong Kong. He also served as General Manager of the pharmaceutical distributor Y.C. Woo Co., Ltd. in Hong Kong. He earned a Bachelor of Arts degree in social sciences from the University of Hong Kong, an M.B.A. degree from Henley Management, and an advanced E.M.B.A. from Harvard Business School. since 2013.
Age 64
Tenure 11 years
Professional MarksMBA
Phone650 358-3456
Webwww.sciclone.com
Li’s current nonexecutive activities include serving on the board of directors of Shandong Weigao Group Medical Polymer, and he has received several industry honors. He earned a Bachelor of Arts degree in social sciences from the University of Hong Kong, an M.B.A. degree from Henley Management, and an advanced E.M.B.A. from Harvard Business School.

SciClone Pharmaceuticals Management Efficiency

The company has return on total asset (ROA) of 0.16 % which means that it generated a profit of $0.16 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.19 %, meaning that it created $0.19 on every $100 dollars invested by stockholders. SciClone Pharmaceuticals' management efficiency ratios could be used to measure how well SciClone Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 2.73 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. SciClone Pharmaceuticals has a current ratio of 8.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist SciClone Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, SciClone Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like SciClone Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for SciClone to invest in growth at high rates of return. When we think about SciClone Pharmaceuticals' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Robert PageRave Restaurant Group
58
Steven ShulmanArk Restaurants Corp
76
William JohnsonBiglari Holdings
71
Arthur StainmanArk Restaurants Corp
75
Guisela NunezArk Restaurants Corp
N/A
Marcia AllenArk Restaurants Corp
67
Douglas SchmickThe Cheesecake Factory
67
William HammettRave Restaurant Group
71
Laurence MindelThe Cheesecake Factory
80
Ramon PhillipsRave Restaurant Group
84
Jerome KransdorfThe Cheesecake Factory
79
Clinton ColemanRave Restaurant Group
40
Alexander CappelloThe Cheesecake Factory
62
Herbert SimonThe Cheesecake Factory
83
Steven JohnsonRave Restaurant Group
56
Marilyn GuyArk Restaurants Corp
N/A
James MastrianBiglari Holdings
76
David PittawayThe Cheesecake Factory
66
Vincent PascalArk Restaurants Corp
81
Kenneth CooperBiglari Holdings
75
Stephen NovickArk Restaurants Corp
77
SciClone Pharmaceuticals, Inc., a specialty pharmaceutical company, offer therapies for oncology, infectious diseases, and cardiovascular disorders in the People?s Republic of China, the United States, and Hong Kong. SciClone Pharmaceuticals (SCLN) is traded on NASDAQ Exchange in USA and employs 590 people.

Management Performance

SciClone Pharmaceuticals Leadership Team

Elected by the shareholders, the SciClone Pharmaceuticals' board of directors comprises two types of representatives: SciClone Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SciClone. The board's role is to monitor SciClone Pharmaceuticals' management team and ensure that shareholders' interests are well served. SciClone Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SciClone Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Charles Meng, VP of Compliance and General Counsel
Richard Hawkins, Independent Director
Gregg Lapointe, Independent Director
Hong Zhao, CEO of China Operations
Wilson Cheung, CFO, Sr. VP of Fin. and Secretary
Nancy Chang, Director
Anthony Lapointe, Independent Director
Lan Xie, VP of Fin. and CFO of China Operations
Raymond Low, Vice President - Finance, Controller
Robert King, Senior Vice President - Product Development and Supply Chain
Simon Li, Independent Director
Jon Saxe, Independent Chairman of the Board
Friedhelm Blobel, CEO and President Executive Director and Member of Bus. Devel. Committee

SciClone Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SciClone Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards SciClone Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, SciClone Pharmaceuticals' short interest history, or implied volatility extrapolated from SciClone Pharmaceuticals options trading.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Consideration for investing in SciClone Stock

If you are still planning to invest in SciClone Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SciClone Pharmaceuticals' history and understand the potential risks before investing.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges